Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             192 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Author Index 2007
 31 S2 p. S117-S121
5 p.
 artikel
2 E02 Autologous haematopoetic cell transplantation for acute myeloblastic leukaemia Holowiecki, J.
 2007
 31 S2 p. S7-S9
3 p.
 artikel
3 E01 Biology, cytogenetics and molecular studies in acute myeloid leukemia Mrózek, K.
 2007
 31 S2 p. S3-S7
5 p.
 artikel
4 E04 Early aggressive chemotherapy seen as the key to advanced Hodgkin lymphoma relapse rates Diehl, V.
 2007
 31 S2 p. S10-S12
3 p.
 artikel
5 E09 Insights into the pathogenesis & therapy of myeloproliferative disease from mouse models Zaleskas, V.
 2007
 31 S2 p. S19-S20
2 p.
 artikel
6 E05 New issues in the management of localized Hodgkin's lymphoma Canellos, G.P.
 2007
 31 S2 p. S12-S13
2 p.
 artikel
7 E08 New tyrosine kinase inhibitors in chronic myeloid leukemia (CML) Kantarjian, H.
 2007
 31 S2 p. S16-S19
4 p.
 artikel
8 E13 Non-Hodgkin lymphoma: how to proceed Aurer, I.
 2007
 31 S2 p. S23-S25
3 p.
 artikel
9 E11 Predicated health consequences of the Chernobyl nuclear power station accident 1986–2065 Gale, R.P.
 2007
 31 S2 p. S21-S22
2 p.
 artikel
10 E10 Stem cell transplantation for multiple myeloma in Croatia: evaluation of the efficacy of double autologous stem cell transplantation Nemet, D.
 2007
 31 S2 p. S20-S21
2 p.
 artikel
11 E07 Stem cell transplantation in ALL: a donor versus no donor comparison in the EORTC ALL-4 study Labar, B.
 2007
 31 S2 p. S15-S16
2 p.
 artikel
12 E15 Therapy for chronic lymphocytic leukemia (CLL): how to proceed Jakšić, B.
 2007
 31 S2 p. S27-S29
3 p.
 artikel
13 E14 Therapy for CLL: current approach, future trends Keating, M.J.
 2007
 31 S2 p. S25-S26
2 p.
 artikel
14 E12 Therapy for T-cell non-Hodgkin's lymphoma Vose, J.M.
 2007
 31 S2 p. S22-S23
2 p.
 artikel
15 E03 Treatment of Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) Ottman, O.
 2007
 31 S2 p. S9-S10
2 p.
 artikel
16 E06 Unrelated donor (MUD) haematopoietic stem cell transplantation in patients with myeloid malignancies Petersen, F.B.
 2007
 31 S2 p. S13-S15
3 p.
 artikel
17 OP12 Allogeneic stem cell transplantation for AML: does conditioning intensity matter? Blaise, D.
 2007
 31 S2 p. S37-S38
2 p.
 artikel
18 OP10 AML in children: treatment approach in St. Jude Burnett, A.
 2007
 31 S2 p. S35-S36
2 p.
 artikel
19 OP11 AMLinolderpatients:theEORTC/GIMEMA experience Amadori, S.
 2007
 31 S2 p. S36-S37
2 p.
 artikel
20 OP17 Arsenic trioxid improves survival in first line APL consolidation treatment: the NCI/CALGB study results Lo Coco, F.
 2007
 31 S2 p. S41-
1 p.
 artikel
21 OP05 ATG for pure red cell aplasia: case series Zupančić-Šalek, S.
 2007
 31 S2 p. S33-
1 p.
 artikel
22 OP53 Autologous versus allogenic stem cell transplantation for multiple myeloma Attal, M.
 2007
 31 S2 p. S58-
1 p.
 artikel
23 OP50 Bortezomib in the treatment of multiple myeloma Blade, J.
 2007
 31 S2 p. S55-S56
2 p.
 artikel
24 OP34 Changing trends in hematopoietic stem cell transplantation Gratwohl, A.
 2007
 31 S2 p. S48-
1 p.
 artikel
25 OP41 Chronic graft versus host disease: new approaches for transplant greatest challenges Pavletic, S.Z.
 2007
 31 S2 p. S52-
1 p.
 artikel
26 OP18 Classifications of myelodysplastic syndromes (MDS): recent advances Greenberg, P.L.
 2007
 31 S2 p. S41-S42
2 p.
 artikel
27 OP25 Current therapy for ALL in adults Hoelzer, D.
 2007
 31 S2 p. S44-S45
2 p.
 artikel
28 OP58 Current treatment strategies in mantle cell lymphoma Dreyling, M.
 2007
 31 S2 p. S60-
1 p.
 artikel
29 OP14 Design and analysis of clinical trials in acute leukemia: review of a 25-year experience Suciu, S.
 2007
 31 S2 p. S39-
1 p.
 artikel
30 OP46 Diagnosis and management of myeloproliferative disorders in the JAK2 mutations era Tefferi, A.
 2007
 31 S2 p. S54-
1 p.
 artikel
31 OP37 Direct intra-bone injection of unrelated cord blood cells overcomes the problem of delayed engraftment or failure to engraft and improves the feasibility of hematopoietic transplant in adult patients Raiola, A.M.
 2007
 31 S2 p. S49-S50
2 p.
 artikel
32 OP44 Drug resistance in CML Cortes, J.
 2007
 31 S2 p. S53-
1 p.
 artikel
33 OP21 Epigenetic therapy in the biological continuum of MDS and AML Lübbert, M.
 2007
 31 S2 p. S42-S43
2 p.
 artikel
34 OP65 First line therapy for chronic lymphocytic leukemia Montserrat, E.
 2007
 31 S2 p. S62-
1 p.
 artikel
35 OP66 First line therapy with fludarabine, cyclophosphamide and rituximab for CLL Keating, M.J.
 2007
 31 S2 p. S62-S63
2 p.
 artikel
36 OP54 Front-line therapy for indolent B-cell lymphoma McLaughlin, P.
 2007
 31 S2 p. S58-
1 p.
 artikel
37 OP15 Front-line treatment of acute promyelocytic leukemia: the state of the art Sanz, M.A.
 2007
 31 S2 p. S39-S40
2 p.
 artikel
38 OP06 Gene-expression micro-array in AML diagnostics Lowenberg, B.
 2007
 31 S2 p. S34-
1 p.
 artikel
39 OP68 Gene therapy for patients with CLL Wierda, W.G.
 2007
 31 S2 p. S63-S64
2 p.
 artikel
40 OP36 Hematopoietic stem cell transplantation in children and adults with acute leukemia in Europe. A survey on behalf of the Acute Leukaemia and Paediatric Disease Working Party of EBMT Rocha, V.
 2007
 31 S2 p. S49-
1 p.
 artikel
41 OP08 High dose (HD-AraC) vs standard dose cytosine arabinoside (SD-AraC) during induction in acute myelogenous leukemia (AML): Impact on stem cell mobilization after consolidation and on autologous transplantation (AML-12 trial) Willemze, R.
 2007
 31 S2 p. S34-S35
2 p.
 artikel
42 OP33 Hodgkin's lymphoma in Croatia Radman, I.
 2007
 31 S2 p. S47-S48
2 p.
 artikel
43 OP67 Immunotherapy of CLL Kipps, T.J.
 2007
 31 S2 p. S63-
1 p.
 artikel
44 OP32 Late effects in survivors of Hodgkin's lymphoma Carde, P.
 2007
 31 S2 p. S47-
1 p.
 artikel
45 OP20 Low-risk MDS – do we need more than suportive care? Hellstrom-Lindberg, E.
 2007
 31 S2 p. S42-
1 p.
 artikel
46 OP55 Management of relapsed indolent lymphoma Cabanillas, F.
 2007
 31 S2 p. S58-S59
2 p.
 artikel
47 OP39 Mechanisms of graft-versus-leukaemia reactions (GvL) in chimeras Kolb, H.J.
 2007
 31 S2 p. S50-S51
2 p.
 artikel
48 OP63 MicroRNA gene and cancer Croce, C.M.
 2007
 31 S2 p. S61-
1 p.
 artikel
49 OP35 Modulation of immune responses by mesenchimal stem cells Fibbe, W.
 2007
 31 S2 p. S48-S49
2 p.
 artikel
50 OP45 Molecular pathogenesis and management of MPDs Green, A.R.
 2007
 31 S2 p. S53-S54
2 p.
 artikel
51 OP27 More intensive chemotherapy for young adults with ALL? Marrie, J.P.
 2007
 31 S2 p. S45-
1 p.
 artikel
52 OP09 MRC trials in acute myeloid leukaemia Burnett, A.
 2007
 31 S2 p. S35-
1 p.
 artikel
53 OP49 Multiple myelomas – dissecting distinct biological entities by gene expression profiling of plasma cells and microenviroment Shaughnessy, J.D.
 2007
 31 S2 p. S55-
1 p.
 artikel
54 OP24 Myelodysplastic syndrome management in Slovakia Mistrik, M.
 2007
 31 S2 p. S44-
1 p.
 artikel
55 OP48 New therapeutic agents for myeloproliferative disorders Verstovsek, S.
 2007
 31 S2 p. S54-S55
2 p.
 artikel
56 OP23 New therapeutics for myelodysplastic syndromes (MDS) List, A.F.
 2007
 31 S2 p. S43-S44
2 p.
 artikel
57 OP28 Novel agents for ALL O'Brien, S.
 2007
 31 S2 p. S45-S46
2 p.
 artikel
58 OP13 Novel agents in acute myeloid leukemia (AML) Kantarjian, H.M.
 2007
 31 S2 p. S38-S39
2 p.
 artikel
59 OP47 Polycythaemia vera: new approaches, new targets Barbui, T.
 2007
 31 S2 p. S54-
1 p.
 artikel
60 OP59 Radioimmunotherapy for treatment of non-Hodgkin lymphoma Zinzani, P.L.
 2007
 31 S2 p. S60-
1 p.
 artikel
61 OP38 Reduced intensity conditioning hematopoietic cell transplants in elderly patients with AML Niederwieser, D.
 2007
 31 S2 p. S50-
1 p.
 artikel
62 OP07 3&7 remains the standard induction therapy for AML Schiffer, C.A.
 2007
 31 S2 p. S34-
1 p.
 artikel
63 OP57 Risk adapted treatment of young patients with DLBCL Pfreundschuh, M.
 2007
 31 S2 p. S59-S60
2 p.
 artikel
64 OP56 Rituximab maintenance treatment in follicular lymphoma Hagenbeek, A.
 2007
 31 S2 p. S59-
1 p.
 artikel
65 OP30 Role of radiation therapy in treating Hodgkin's disease Hoppe, R.T.
 2007
 31 S2 p. S46-
1 p.
 artikel
66 OP04 Safety and efficacy of the terminal complement inhibitor eculizumab in patients with paroxysmal nocturnal hemoglobinuria: Shepherd Phase III clinical study results Muus, P.
 2007
 31 S2 p. S32-S33
2 p.
 artikel
67 OP03 Should we treat ALL as one disease? Hoelzer, D.
 2007
 31 S2 p. S32-
1 p.
 artikel
68 OP61 Stem cell allotransplantation for NHL Maloney, D.G.
 2007
 31 S2 p. S60-
1 p.
 artikel
69 OP22 Stem cell transplantation (SCT) for MDS de Witte, T.
 2007
 31 S2 p. S43-
1 p.
 artikel
70 OP43 Stem cell transplant for CML – with or without tyrosine kinase inhibitors Apperley, J.
 2007
 31 S2 p. S52-
1 p.
 artikel
71 OP40 Techniques to optimize GvT/GvL effects and improve immune reconstitution Barrett, J.
 2007
 31 S2 p. S51-S52
2 p.
 artikel
72 OP52 The pursuit of cure in multiple myeloma (MM) – the Arkansas approach Barlogie, B.
 2007
 31 S2 p. S57-
1 p.
 artikel
73 OP64 Therapeutic approaches in front-line therapy in chronic lymphocytic leukemia Rai, K.R.
 2007
 31 S2 p. S61-S62
2 p.
 artikel
74 OP60 Therapy for relapsed/refractory aggressive NHL Zelenetz, A.D.
 2007
 31 S2 p. S60-
1 p.
 artikel
75 OP26 Therapy of Burkitt's and lymphoblastic lymphoma, and PH+ ALL at MDACC Thomas, D.
 2007
 31 S2 p. S45-
1 p.
 artikel
76 OP29 Therapy of Hodgkin's lymphoma in MDACC Hagemeister, F.B.
 2007
 31 S2 p. S46-
1 p.
 artikel
77 OP16 The role of arsenic trioxid in APL today, from expert consensus to European guidelines Lo Coco, F.
 2007
 31 S2 p. S40-S41
2 p.
 artikel
78 OP51 The role of bisphosphonates in the management of myeloma Berenson, J.R.
 2007
 31 S2 p. S56-S57
2 p.
 artikel
79 OP62 The value of FDG/PET in non-Hodgkin's lymphoma management Trneni, M.
 2007
 31 S2 p. S61-
1 p.
 artikel
80 OP19 Transfusion dependence and iron overload and prognostic modelling of MDS Greenberg, P.L.
 2007
 31 S2 p. S42-
1 p.
 artikel
81 OP01 Treatment of acute leukemia: 50 years later Freireich, E.
 2007
 31 S2 p. S31-
1 p.
 artikel
82 OP02 Unrelated cord blood transplantation in children and adults with leukemias and lymphomas Gluckman, E.
 2007
 31 S2 p. S31-S32
2 p.
 artikel
83 OP42 Update on CML therapy with imatinib, and treatment outcome monitoring Talpaz, M.
 2007
 31 S2 p. S52-
1 p.
 artikel
84 OP31 10-year results of the HD9 trial of the German Hodgkin Study Group comparing baseline and escalated BEACOPP chemotherapy for advanced Hodgkin lymphoma Engert, A.
 2007
 31 S2 p. S46-S47
2 p.
 artikel
85 P071 ABVP protocol for primary treatment of advanced adult Hodgkin disease: the Casablanca experience Qachouh, M.
 2007
 31 S2 p. S96-
1 p.
 artikel
86 P001 Acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma carrying mutated CCAAT/enhancer-binding protein alpha Fuchs, O.
 2007
 31 S2 p. S65-
1 p.
 artikel
87 P092 Acute myelomonocytic leukemia after HSCT with reduced intensity conditioning for CLL: a case report Serventi-Seiwerth, R.
 2007
 31 S2 p. S105-S106
2 p.
 artikel
88 P017 Acute promyelocytic leukemia in an HIV-infected patient – a case report Boban, A.
 2007
 31 S2 p. S72-
1 p.
 artikel
89 P096 After the 100th autologous peripheral haemopoietic stem cell transplantation in the 2nd Department of the Medicine, University of Debrecen, Hungary Kiss, A.
 2007
 31 S2 p. S107-
1 p.
 artikel
90 P078 Aggressive T-anaplastic large cell non-Hodgkin lymphoma in patient with chromosome breakage syndrome - a case report Kinda Bašić, S.
 2007
 31 S2 p. S99-
1 p.
 artikel
91 P086 Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphopma: unicentric experience Postorino, M.
 2007
 31 S2 p. S102-S103
2 p.
 artikel
92 P013 All-transretinoic acid (ATRA) in the treatment of acute promyelocytic leukemia - 15 years of single centre experience Szotkowski, T.
 2007
 31 S2 p. S70-
1 p.
 artikel
93 P073 Analysis of B-cell clonality in composite Hodgkin disease and non-Hodgkin's lymphoma Antic, D.
 2007
 31 S2 p. S97-
1 p.
 artikel
94 P027 A new international registry for patients with chronic myeloid leukemia: CAMELIA Faber, E.
 2007
 31 S2 p. S76-S77
2 p.
 artikel
95 P101 Antimycotic prophylaxis in stem cell recipients – single center expirience Stojanoski, Z.
 2007
 31 S2 p. S110-
1 p.
 artikel
96 P014 ARA-C and gemtuzumab ozogamicin (ARA-GO) is effective and safe therapy for elderly AML patient Tóthová, E.
 2007
 31 S2 p. S70-S71
2 p.
 artikel
97 P094 Autologous blood stem cell (PBSCT) vs bone marrow transplantation (ABMT) for acute myeloid leukaemia in 1st remission Duraković, N.
 2007
 31 S2 p. S106-
1 p.
 artikel
98 P034 Bone marrow renin-angiotensin system expression in polycythaemia vera and essential thrombocythaemia depends on JAK2 mutational status Marusic Vrsalovic, M.
 2007
 31 S2 p. S80-
1 p.
 artikel
99 P102 Bone marrow trabnsplantation for acute myeloid leukemia from donor with Gaucher disease followed by enzyme replacement therapy (ERT) Mrsić, M.
 2007
 31 S2 p. S110-S111
2 p.
 artikel
100 P043 Bortezomib plus dexametasone in relapsed and refractory multiple myeloma: standard, weekly and retreatment modalities López, J.A.
 2007
 31 S2 p. S84-
1 p.
 artikel
101 P006 Burkitt lymphoma in adults: how to treat? Baryakh, E.
 2007
 31 S2 p. S67-S68
2 p.
 artikel
102 P003 CD11a, myeloperoxidase and alkaline phosphatase expression in bone marrow mature granulopoietic cells in patients with AML and ALL Sučić, M.
 2007
 31 S2 p. S66-
1 p.
 artikel
103 P004 Changes in thymic recent output function in patients with acute myeloid leukemia Li, Y.
 2007
 31 S2 p. S66-S67
2 p.
 artikel
104 P030 Chronic myelogenous leukemia Casablanca experience retrospective study about 431 cases Fk, M.
 2007
 31 S2 p. S78-
1 p.
 artikel
105 P040 Chronic natural killer cell lymphocytosis Grković, L.
 2007
 31 S2 p. S82-S83
2 p.
 artikel
106 P055 Clinical and morphological characteristics of non-Hodgkin's lymphomas Babkina, A.V.
 2007
 31 S2 p. S89-
1 p.
 artikel
107 P054 Clinical and morphological characteristics of non-Hodgkin's lymphomas Poddubnaya, I.
 2007
 31 S2 p. S89-
1 p.
 artikel
108 P036 Clinical data of CLL patients with unmutated IGHV1-69 gene expression Abramenko, I.
 2007
 31 S2 p. S81-
1 p.
 artikel
109 P042 Clinical stage-depending decrease of NK cell activity in multiple myeloma patients Jurisic, V.
 2007
 31 S2 p. S83-S84
2 p.
 artikel
110 P068 Comparative efficacy analysis of rituximab monotherapy and rituximab plus cyclo-phosphamide, doxorubicin, vincristine and predisone (R-CHOP) regimen in relapsed and refractory non-Hodgkin's lymphoma Lutskaya, T.
 2007
 31 S2 p. S95-
1 p.
 artikel
111 P091 Cord blood banking in Croatia Golubić-Ćepulić, B.
 2007
 31 S2 p. S105-
1 p.
 artikel
112 P052 Cytogenetic impact in differential diagnostics of Burkitt lymphoma and other high proliferated lymphomas Baryakh, E.
 2007
 31 S2 p. S88-
1 p.
 artikel
113 P038 Determined treatment with the fludarabine and the cyclophosphamide of the resistant and relapsed B-CLL patients on the base of B-cells sensitivity in vitro Kataeva, E.
 2007
 31 S2 p. S82-
1 p.
 artikel
114 P099 Efficacy and safety of colistin for the treatment of infections caused by multidrug-resistant isolates of Pseudomonas aeruginosa sensitive to colistin in patients with haematological malignancy Durakovic, N.
 2007
 31 S2 p. S108-S109
2 p.
 artikel
115 P044 Efficacy of single-agent bortezomib and combination of bortezomib, melphalan, prednison in patients with relapsed and refractory multiple myeloma associated with poor clinical parameters Golenkov, A.
 2007
 31 S2 p. S84-S85
2 p.
 artikel
116 P082 Enhancement of immune and hematopoietic reconstitution by IL-7 following experimental bone marrow transplantation in a murine model may be mediated by IL-2 and RAG-1 activation Abdul-Hai, A.
 2007
 31 S2 p. S100-S101
2 p.
 artikel
117 P012 Epidemiological features of leukaemias in Federation of Bosnia and Herzegovina from 1992 to 2000 Bijedić, V.
 2007
 31 S2 p. S70-
1 p.
 artikel
118 P022 Evaluation of some hemostatic parameters in patients with end-stage renal disease: relation to dyslipidemia and hemodialysis therapy Abou Samra, N.
 2007
 31 S2 p. S74-
1 p.
 artikel
119 P084 Excellent anti-leukaemic efficacy of allogeneic-SCT after FLAMSA chemotherapy and reduced intensity conditioning in patients with high risk myeloid malignancies aged 60 years or older Schleuning, M.
 2007
 31 S2 p. S101-S102
2 p.
 artikel
120 P087 Final height of children after stem cell transplan Kook, H.
 2007
 31 S2 p. S103-
1 p.
 artikel
121 P067 FMC/FMC-R regiments efficiency in treatment of primary ocular adnexal MALT-lymphomas Krasilnikova, B.
 2007
 31 S2 p. S94-S95
2 p.
 artikel
122 P020 Genetic and environmental determinants of plasma fibrinogen levels in geographically isolated population Pulanić, D.
 2007
 31 S2 p. S73-S74
2 p.
 artikel
123 P016 Granulocytic sarcoma: single institution expirience Antic, D.
 2007
 31 S2 p. S71-S72
2 p.
 artikel
124 P089 HLA microsatellites analysis: implications for unrelated donor matching in hematopoietic stem cell transplantation Stingl, K.
 2007
 31 S2 p. S104-
1 p.
 artikel
125 P037 IgHV gene repertoire and HCDR3 region compositions in Ukrainian B-CLL patients Bilous, N.
 2007
 31 S2 p. S81-S82
2 p.
 artikel
126 P031 Imatinib and aging: preliminary evaluation of efficacy and toxicity of two CML groups Tóthová, E.
 2007
 31 S2 p. S78-S79
2 p.
 artikel
127 P051 Immunohistochemical expression patterns of germinal center and activation B-cell markers do not correlate with prognosis in diffuse large B-cell lymphoma treated with R-CHOP Mitrovic, Z.
 2007
 31 S2 p. S87-S88
2 p.
 artikel
128 P009 Improved therapeutic outcome in children with acute lymphoblastic leukemia in Croatia Konja, J.
 2007
 31 S2 p. S69-
1 p.
 artikel
129 P024 Inhibition of heat shock protein 90 prolongs survival of mice with BCR-ABL-T3151-induced leukemia suppresses leukemic stem cells Peng, C.
 2007
 31 S2 p. S75-S76
2 p.
 artikel
130 P056 International prognostic index, bulky disease, Ki67, bcl-2 and the outcome in newly diagnosed patients with diffuse large B cell lymphoma Perunicic Jovanovic, M.
 2007
 31 S2 p. S89-S90
2 p.
 artikel
131 P019 JAK2 V617F and FLT3 ITD mutation in myelodysplastic syndrome Radić Antolic, M.
 2007
 31 S2 p. S73-
1 p.
 artikel
132 P035 JAK2 V617F mutation and the clinical features in myeloproliferative disorders Radić Antolic, M.
 2007
 31 S2 p. S80-
1 p.
 artikel
133 P098 LightCycler Septifast assay as a tool for the rapid diagnosis of sepsis in patients during antimicrobial therapy Vince, A.
 2007
 31 S2 p. S108-
1 p.
 artikel
134 P032 Long term follow up of a patient with chronic myeloid leukemia treated with umbilical cord blood transplantation, buffy coat and interferon-α Boban, A.
 2007
 31 S2 p. S79-
1 p.
 artikel
135 P095 Long term follow up of autologous transplant in AML patients in first complete remission Cevreska, L.
 2007
 31 S2 p. S106-S107
2 p.
 artikel
136 P059 Long-term results of CHOP/CHOP like chemotherapy ± rituximab in patients with diffuse large B-cell lymphoma (DLBCL) Mihaljevic, B.
 2007
 31 S2 p. S91-
1 p.
 artikel
137 P063 Mechanisms of action of rituximab and its effectiveness in high risk patients with aggressive CD20+ lymphoma Jezersek Novaković, B.
 2007
 31 S2 p. S93-
1 p.
 artikel
138 P045 MGUS and myelomonocytic leukemia – a case report Heloisa, H.
 2007
 31 S2 p. S85-
1 p.
 artikel
139 P002 Microenvironment influence on cyclin A1 mRNA expression in AML blasts Golemović, M.
 2007
 31 S2 p. S65-S66
2 p.
 artikel
140 P058 Modified NHL-BFM-90 program in primary gastric diffuse large B-cell lymphoma (PGDLBCL) with adverse prognostic factors Zvonkov, E.
 2007
 31 S2 p. S90-S91
2 p.
 artikel
141 P041 Molecular detection and clinics of IgH/MMSET of t(4;14)(4p16;14q32) in multiple myeloma Kusec, R.
 2007
 31 S2 p. S83-
1 p.
 artikel
142 P090 Molecular detection of Epstein-Barr virus in patients with bone marrow transplantation Vince, A.
 2007
 31 S2 p. S104-S105
2 p.
 artikel
143 P028 Monitoring CML patients responding to treatment with tyrosine kinase inhibitors with real-time quantitative polymerase chain reaction Radić Antolic, M.
 2007
 31 S2 p. S77-S78
2 p.
 artikel
144 P018 mTOR inhibitor rapamycin interacts synergistically with farnesyltransferase inhibitor FTI-277 to induce growth inhibition in human leukemia cells Min, Y.H.
 2007
 31 S2 p. S72-S73
2 p.
 artikel
145 P021 Multiple relapsing non-melanoma skin cancers in patient with severe hemophilia A – a case report Zupančić-Šalek, S.
 2007
 31 S2 p. S74-
1 p.
 artikel
146 P025 Mutation of the P53 gene is associated with blastic transformation in chronic myeloid leukeima El-Sharawy, S.
 2007
 31 S2 p. S76-
1 p.
 artikel
147 P046 Neurologic, hematologic, renal and cardiac complications in patients wirh primary or secondary amiloidosis Gaman, G.
 2007
 31 S2 p. S85-
1 p.
 artikel
148 P008 Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study Abdelrazik, N.
 2007
 31 S2 p. S68-
1 p.
 artikel
149 P080 Our experience in treatment of the first patient who came down with the Burkitts lymphoma and AIDS in BiH Dizdarevic, A.
 2007
 31 S2 p. S100-
1 p.
 artikel
150 P015 Outcome in a small series of biphenotypic acute leukemia (BAL) patients Mikulic, M.
 2007
 31 S2 p. S71-
1 p.
 artikel
151 P088 PCR-STR method in monitoring chimerism status after hematopoietic stem cell transplantation Grubic, Z.
 2007
 31 S2 p. S103-S104
2 p.
 artikel
152 P011 Pneumomediastinum complicating childhood non-Hodgkin lymphoma – case report Roganović, J.
 2007
 31 S2 p. S69-S70
2 p.
 artikel
153 P100 Predictors of outcome for patients with haematological malignancies in ICU Gasparovic, V.
 2007
 31 S2 p. S109-S110
2 p.
 artikel
154 P069 Primary CNS lymphomas: the treatment experience within one center Gubkin, A.
 2007
 31 S2 p. S95-
1 p.
 artikel
155 P070 Primary diffuse large B-cell lymphoma of the spleen Magomedova, A.
 2007
 31 S2 p. S95-S96
2 p.
 artikel
156 P076 Primary low grade marginal zone B-cell uterine lymphoma: a case report López López, J.A.
 2007
 31 S2 p. S98-
1 p.
 artikel
157 P053 Prognostic and predictive significance of CD10 expression in diffuse large B cell lymphoma Sofo Hafizović, A.
 2007
 31 S2 p. S88-S89
2 p.
 artikel
158 P072 Prognostic role of FDG-PET in clinical management of Hodgkin lymphoma patients with residual mass – long term follow-up Marton, I.
 2007
 31 S2 p. S96-
1 p.
 artikel
159 P005 Prognostic significance of the different multidrug resistance proteins co-expression in acute myeloid leukemia Zakharov, O.
 2007
 31 S2 p. S67-
1 p.
 artikel
160 P023 Relationship between insulin resistance and some coagulation and fibrinolytic parameters in subjects with metabolic syndrome Ragab, A.
 2007
 31 S2 p. S75-
1 p.
 artikel
161 P062 Results of RCHOP6 or RCHOP8 study in the treatment of patients with diffuse large B-cell lymphoma – single institution study Trajkova, S.
 2007
 31 S2 p. S92-
1 p.
 artikel
162 P057 Roles of flow cytometry in bone marrow staging of B-cell non-Hodgkin lymphoma Na Nakorn, C.
 2007
 31 S2 p. S90-
1 p.
 artikel
163 P075 Secondary malignancies after Hodgkin's disease Bašić-Kinda, S.
 2007
 31 S2 p. S98-
1 p.
 artikel
164 P049 Serum level of intercellular adhesion molecule-1 (ICAM-1) in patients with malignant lymphoma Abdelrazik, N.
 2007
 31 S2 p. S86-S87
2 p.
 artikel
165 P083 Simultaneous haploidentically mismatched stem cell transplantation from multi-donors (MDT) in humans offers better engraftment as compared to single donor Shapira, M.Y.
 2007
 31 S2 p. S101-
1 p.
 artikel
166 P081 Spontaneous splenic rupture in two patients with hematologic malignancy Szotkowski, T.
 2007
 31 S2 p. S100-
1 p.
 artikel
167 P065 Survival benefits of patients with non-Hodgkin's lymphoma treated with rituximab combined with chemotherapy Kafková, A.
 2007
 31 S2 p. S93-S94
2 p.
 artikel
168 P050 Susceptibility of non-Hodgkin's lymphoma associated with polymorphic variants in folate pathway genes Kim, H.J.
 2007
 31 S2 p. S87-
1 p.
 artikel
169 P007 Systemic/high-dose methotrexate and leucovorin "rescue" issues in children with lymphoblastic malignancies: continuing inconsistencies Jaroslav, S.
 2007
 31 S2 p. S68-
1 p.
 artikel
170 P077 The abeyance or initial drastic tratment in mycosis fungoides variants Gaman, G.
 2007
 31 S2 p. S98-S99
2 p.
 artikel
171 P047 The bi-specific T-cell enhancer (BiTE) MT103 (MEDI-538) shows clinical activity in pre-treated NHL: update from the ongoing Phase I study MT103-104 Zugmaier, G.
 2007
 31 S2 p. S85-S86
2 p.
 artikel
172 P039 The clinical outcome in patients with T-cell chronic lymphocytic leukemia Sretenovic, A.
 2007
 31 S2 p. S82-
1 p.
 artikel
173 P066 The combination of rituximab and HyperCVAD in treatment of Burkitt lymphoma – a single institution expirience Jankovic, S.
 2007
 31 S2 p. S94-
1 p.
 artikel
174 P060 The influence of international prognostic score and bulky disease in patients with primary mediastinal B sclerosing lymphoma treated with immunochemotherapy Mihaljevic, B.
 2007
 31 S2 p. S91-
1 p.
 artikel
175 P033 The JAK kinase inhibitor CP-690,550 supresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation Manshouri, T.
 2007
 31 S2 p. S79-
1 p.
 artikel
176 P079 The prognosis of AIDS-related non-Hodgkin's lymphoma: the experience of the Serbian Lymphoma Study Group (SLG) Djunic, I.
 2007
 31 S2 p. S99-
1 p.
 artikel
177 P074 The prognostic value of the expression of p53, Ki67, EBV-LMP, bcl-6 and pRb in patients with Hodgkin's lymphoma Antic, D.
 2007
 31 S2 p. S97-
1 p.
 artikel
178 P048 The usefulness of T-cell receptor gene rearrangement in Thai patients Tanawan, K.
 2007
 31 S2 p. S86-
1 p.
 artikel
179 P097 Toxicity related to autologous peripheral blood hematopoietic progenitor cell infusion is associated with number of granulocytes in graft, gender and diagnosis of multiple myeloma Bojanić, I.
 2007
 31 S2 p. S107-S108
2 p.
 artikel
180 P010 Treatment of adolescents with acute lymphoblastic leukemia Konja, J.
 2007
 31 S2 p. S69-
1 p.
 artikel
181 P029 Treatment of chronic myeloid leukemia with interferon and imatinib: results from the northern Moravia Faber, E.
 2007
 31 S2 p. S78-
1 p.
 artikel
182 P064 Treatment of pediatric diffuse large B-cell non-Hodgkin's lymphomas with intensive chemotherapy + rituximab: preliminary results Samochatova, E.
 2007
 31 S2 p. S93-
1 p.
 artikel
183 P085 Treatment of steroid refractory graft vs. host disease by intra-arterial infusion Shapira, M.Y.
 2007
 31 S2 p. S102-
1 p.
 artikel
184 P026 Variant Philadelphia translocation in chronic myeloid leukemia Lasan-Trčić, R.
 2007
 31 S2 p. S76-
1 p.
 artikel
185 P061 90Y-Ibritumomab treatment for relapsed and/or refractory B cell type non-Hodgkin's lymphoma. Multiinstitutional Argentinian study Cacchione, R.
 2007
 31 S2 p. S92-
1 p.
 artikel
186 P093 Zevalin-BEAM conditioning therapy for autologous peripheral stem cell transplantation (PSCT) in patients with follicular non-Hodgkin lymphoma Reményi, G.
 2007
 31 S2 p. S106-
1 p.
 artikel
187 S05 Chelation therapy in transfusional iron overload: Exjade efficacy and safety Cappellini, M.D.
 2007
 31 S2 p. S115-
1 p.
 artikel
188 S06 Clinical relevance and treatment of transfusional iron overload in myelodysplastic syndromes Malcovati, L.
 2007
 31 S2 p. S116-
1 p.
 artikel
189 S01 Imatinib mesylate in chronic myeloid leukemia (CML). 5-year update of the IRIS trial Kantarjian, H.M.
 2007
 31 S2 p. S112-
1 p.
 artikel
190 S04 Mechanisms of transfusional iron overload toxicity and monitoring of iron overload Porter, J.
 2007
 31 S2 p. S114-S115
2 p.
 artikel
191 S02 Molecular monitoring and ELN guidelines for CML Goldman, J.
 2007
 31 S2 p. S112-S113
2 p.
 artikel
192 S03 Novel TKI therapies for CML: targeting Bcr-Abl with Tasigna Talpaz, M.
 2007
 31 S2 p. S114-
1 p.
 artikel
                             192 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland